Medicare

Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes

Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes

Pills and money illustration
ADOBE

As controversy continues over prescription drug pricing, a new study finds that Medicare Part D spent $2 billion more for brand-name medicines in 2015 than four years earlier, even though drug makers offered rebates to win favorable coverage from health plans.

Specifically, reimbursement to pharmacies for more than 1,500 brand-name medicines rose 19% from 2011 to 2015, while manufacturer rebates offered Medicare Part D plan sponsors increased 4% during that time, according to the Office of Inspector General of the Department of Health and Human Services, which ran the analysis in response to a request from Congress.

Source: https://www.statnews.com/pharmalot/2019/09/17/medicare-drug-prices-rebates-oig/

Posted in Medicare